Worth reading
62In focus
Scored from 4 of 5 sectionsDirection
Improvement
Direction inferred from the company’s description.Scale
2000000
Number of potential sharesWording
Conditional
How definitive the wording is.Details of issuance or disposal
Partial transfer of Series 9 Stock Acquisition Rights
発行・処分する株式数
20,000 rights (100 shares per right; underlying shares: 2,000,000)
Intended allottee
Name Misaki Yuta (三崎 優太) / Number of stock acquisition rights 20,000 rights (2,000,000 shares)
Terms of the stock acquisition rights
Exercise price
Initial exercise price: ¥150 per share, fixed. No adjustment clause.
Exercise period
1 April 2026 to 31 March 2028
Number of Stock Acquisition Rights
Total issued: 213,334 rights; remaining unexercised: 178,334 rights. Following the transfer, 158,334 unexercised rights will be held by KANDB, and 20,000 rights will be transferred to Misaki Yuta (三崎 優太).
Intended allottee's holding policy
For pure investment purposes. The common shares acquired through exercise may be sold, taking market conditions into consideration.
Procedures under the Corporate Code of Conduct
Approval by the Company's Board of Directors. The Company received an investigation report from 株式会社TMR, an independent investigation firm, concerning relationships with anti-social forces and other such entities on 16 June 2026.
Most recent equity financing
Timing 31 March 2026 / Type Issuance of new shares through a third-party allotment and issuance of Series 9 Stock Acquisition Rights / Amount Funds raised through the Series 9 Stock Acquisition Rights: ¥3,202,783,342 (¥2,773,342 from the issuance of the Stock Acquisition Rights and ¥3,200,010,000 from the exercise of the Stock Acquisition Rights)
Impact on Business Performance
The transfer of these stock acquisition rights will have no impact on the Company's operating results. However, as the transfer is expected to lead to early exercise, the Company believes that it will contribute to progress under its business plan and help enhance corporate value over the medium to long term.
| Item | Details |
|---|---|
| Type of issuance or disposal | Partial transfer of Series 9 Stock Acquisition Rights |
| Number of shares to be issued or disposed of | 20,000 rights (100 shares per right; underlying shares: 2,000,000) |
| Intended allottee | Name Misaki Yuta (三崎 優太) / Number of stock acquisition rights 20,000 rights (2,000,000 shares) |
| Intended allottee's holding policy | For pure investment purposes. The common shares acquired through exercise may be sold, taking market conditions into consideration. |
| Exercise price | Initial exercise price: ¥150 per share, fixed. No adjustment clause. |
| Exercise period | 1 April 2026 to 31 March 2028 |
| Number of Stock Acquisition Rights | Total issued: 213,334 rights; remaining unexercised: 178,334 rights. Following the transfer, 158,334 unexercised rights will be held by KANDB, and 20,000 rights will be transferred to Misaki Yuta (三崎 優太). |
| Procedures under the Corporate Code of Conduct | Approval by the Company's Board of Directors. The Company received an investigation report from 株式会社TMR, an independent investigation firm, concerning relationships with anti-social forces and other such entities on 16 June 2026. |
| Most recent equity financing | Timing 31 March 2026 / Type Issuance of new shares through a third-party allotment and issuance of Series 9 Stock Acquisition Rights / Amount Funds raised through the Series 9 Stock Acquisition Rights: ¥3,202,783,342 (¥2,773,342 from the issuance of the Stock Acquisition Rights and ¥3,200,010,000 from the exercise of the Stock Acquisition Rights) |
| Impact on Business Performance | The transfer of these stock acquisition rights will have no impact on the Company's operating results. However, as the transfer is expected to lead to early exercise, the Company believes that it will contribute to progress under its business plan and help enhance corporate value over the medium to long term. |
Items this document does not state (18)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateDilution RateTotal number of issued sharesBasis for determining the amount to be paidTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offering
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Because there is concern that exercise of the rights by KANDB may be delayed due to the depressed share price, a portion will be transferred to an investor intending to exercise the rights over the medium to long term, thereby meeting funding needs through early exercise and increasing the likelihood of stabilizing the financial base.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.